Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 436476, 12 pages
http://dx.doi.org/10.1155/2014/436476
Research Article

Adipose-Derived Stem Cells Ameliorate Allergic Airway Inflammation by Inducing Regulatory T Cells in a Mouse Model of Asthma

1Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University Hospital, Busan 602-739, Republic of Korea
2Department of Parasitology, Pusan National University School of Medicine, Yangsan 626-870, Republic of Korea
3Department of Internal Medicine, Pusan National University Hospital, Busan 602-739, Republic of Korea
4Department of Otorhinolaryngology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Beom-eo li, Mul-geum eup, Yang-san si, Gyeongsangnam-do, Yangsan 626-770, Republic of Korea

Received 18 April 2014; Revised 3 July 2014; Accepted 10 July 2014; Published 26 August 2014

Academic Editor: Alex Kleinjan

Copyright © 2014 Kyu-Sup Cho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bousquet, N. Khaltaev, A. A. Cruz et al., “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen),” Allergy, vol. 63, no. 86, pp. 8–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Cohn, J. A. Elias, and G. L. Chupp, “Asthma: mechanisms of disease persistence and progression,” Annual Review of Immunology, vol. 22, pp. 789–815, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Wilson, M. D. Taylor, A. Balic, C. A. M. Finney, J. R. Lamb, and R. M. Maizels, “Suppression of allergic airway inflammation by helminth-induced regulatory T cells,” Journal of Experimental Medicine, vol. 202, no. 9, pp. 1199–1212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. K. S. Cho, H. Y. Park, H. J. Roh, D. T. Bravo, P. H. Hwang, and J. V. Nayak, “Human ethmoid sinus mucosa: a promising novel tissue source of mesenchymal progenitor cells,” Stem Cell Research & Therapy, vol. 5, article 15, 2014. View at Google Scholar
  5. R. S. Tuan, G. Boland, and R. Tuli, “Adult mesenchymal stem cells and cell-based tissue engineering,” Arthritis Research and Therapy, vol. 5, no. 1, pp. 32–45, 2003. View at Google Scholar · View at Scopus
  6. H. Klingemann, D. Matzilevich, and J. Marchand, “Mesenchymal stem cells—sources and clinical applications,” Transfusion Medicine and Hemotherapy, vol. 35, no. 4, pp. 272–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Uccelli, L. Moretta, and V. Pistoia, “Immunoregulatory function of mesenchymal stem cells,” European Journal of Immunology, vol. 36, no. 10, pp. 2566–2573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Selmani, A. Naji, I. Zidi et al., “Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFOXP3+ regulatory T cells,” Stem Cells, vol. 26, no. 1, pp. 212–222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari, and L. Moretta, “Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2,” Blood, vol. 111, no. 3, pp. 1327–1333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. English, F. P. Barry, and B. P. Mahon, “Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation,” Immunology Letters, vol. 115, no. 1, pp. 50–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. H. K. Park, K. S. Cho, D. H. Shin et al., “Adipose-derived stromal cells inhibit allergic airway inflammation in mice,” Stem Cells and Development, vol. 19, no. 11, pp. 1811–1818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Goodwin, V. Sueblinvong, P. Eisenhauer et al., “Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice,” Stem Cells, vol. 29, no. 7, pp. 1137–1148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. L. Bonfield, M. Koloze, D. P. Lennon, B. Zuchowski, S. E. Yang, and A. I. Caplan, “Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 299, no. 6, pp. L760–L770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. L. Fu, Y. Y. Chow, S. J. Sun et al., “Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis,” Allergy, vol. 67, no. 10, pp. 1215–1222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. K.-S. Cho, H.-K. Park, H.-Y. Park et al., “IFATS collection: immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model,” Stem Cells, vol. 27, no. 1, pp. 259–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Q. Sun, M. X. Deng, J. He et al., “Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice,” Stem Cells, vol. 30, no. 12, pp. 2692–2699, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Cho and H. Roh, “Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases,” Current Stem Cell Research and Therapy, vol. 5, no. 2, pp. 111–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Pellaton-Longaretti, C. Boudousquié, N. Barbier et al., “CD4+CD25-mTGFβ+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthma,” International Immunology, vol. 23, no. 1, pp. 17–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. G. Lee, H. Link, P. Baluk et al., “Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung,” Nature Medicine, vol. 10, no. 10, pp. 1095–1103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. G. Tournoy, J. C. Kips, C. Schou, and R. A. Pauwels, “Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness,” Clinical and Experimental Allergy, vol. 30, no. 1, pp. 79–85, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. H. K. Jin, S. K. Byung, G. U. Tae et al., “γ-secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses,” The American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 10, pp. 875–882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. H. Lee, B. Kim, I. Choi et al., “Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue,” Cellular Physiology and Biochemistry, vol. 14, no. 4–6, pp. 311–324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Puissant, C. Barreau, P. Bourin et al., “Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells,” British Journal of Haematology, vol. 129, no. 1, pp. 118–129, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Jang, K. Cho, H. Park, and H. Roh, “Adipose tissue-derived stem cells for cell therapy of airway allergic diseases in mouse,” Acta Histochemica, vol. 113, no. 5, pp. 501–507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Sueblinvong and D. J. Weiss, “Stem cells and cell therapy approaches in lung biology and diseases,” Translational Research, vol. 156, no. 3, pp. 188–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Wang, B. A. Bunnell, R. G. Painter et al., “Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 1, pp. 186–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Mao, S. N. Wang, X. J. Lv, Y. Wang, and J. C. Xu, “Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats,” Shock, vol. 34, no. 2, pp. 196–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Maccario, M. Podestà, A. Moretta et al., “Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype,” Haematologica, vol. 90, no. 4, pp. 516–525, 2005. View at Google Scholar · View at Scopus
  29. A. Augello, R. Tasso, S. M. Negrini, R. Cancedda, and G. Pennesi, “Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis,” Arthritis & Rheumatism, vol. 56, no. 4, pp. 1175–1186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Hartl, B. Koller, A. T. Mehlhorn et al., “Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma,” Journal of Allergy and Clinical Immunology, vol. 119, no. 5, pp. 1258–1266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry, and B. P. Mahon, “Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells,” Clinical and Experimental Immunology, vol. 156, no. 1, pp. 149–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo, “Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation,” Blood, vol. 103, no. 12, pp. 4619–4621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Nemeth, A. Keane-Myers, J. M. Brown et al., “Bone marrow stromal cells use TGF-β to suppress allergic responses in a mouse model of ragweed-induced asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 12, pp. 5652–5657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Cui, Y. Shuo, W. Liu, N. Li, W. Zhang, and Y. Cao, “Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2,” Tissue Engineering, vol. 13, no. 6, pp. 1185–1195, 2007. View at Publisher · View at Google Scholar · View at Scopus